SpectraBase Spectrum ID |
L5f2ZKYLN70 |
Name |
Pipradrol |
CAS Registry Number |
467-60-7 |
Classification |
Pharmaceutical drug, central stimulant |
Comments |
Spectrum verified by independent measurements in external laboratories |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.14 (f) (10) |
DEA Controlled Substance Name |
Pipradrol |
DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
DEA Controlled Substances Code Number |
1750 |
DEA Schedule |
Schedule IV |
DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers |
Exact Mass |
267.162314299 u |
Formula |
C18H21NO |
InChI |
InChI=1S/C18H21NO/c20-18(15-9-3-1-4-10-15,16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17,19-20H,7-8,13-14H2 |
InChIKey |
XSWHNYGMWWVAIE-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
267.372 g/mol |
Nominal Mass |
267 u |
Quality |
1000 |
Retention Index |
2145 |
SMILES |
OC(C1NCCCC1)(C1=CC=CC=C1)C=1C=CC=CC1 |
SPLASH |
splash10-001i-9000000000-e0996d8d6ad4aa24771a |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
Alpha-pipradrol
Diphenyl-(2-piperidyl)methanol |
Technique |
GC/MS |
Wiley ID |
DD2024_014117 |